On July 30, 2012 the Board of Directors of Human Stem Cells Institute Open Joint-Stock Company elected Aleksandr Prikhodko as Chairman of the Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.54 RUB | +1.43% | -.--% | -.--% |
Apr. 26 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 50.13M | |
+25.91% | 88.08B | |
-24.02% | 75.32B | |
+3.45% | 28.19B | |
+7.05% | 17.78B | |
-13.61% | 16.64B | |
+0.69% | 15.64B | |
+79.76% | 13.81B | |
-26.67% | 13.01B | |
+22.83% | 12.43B |
- Stock Market
- Equities
- ISKJ Stock
- News Human Stem Cells Institute
- Human Stem Cells Institute Open Joint-Stock Company Elects Aleksandr Prikhodko as Chairman of the Board